Skip to content
DraconiticResearch
Search Sources API
197,693 studies31 sourcesUpdated 59 min ago
Peer-reviewedCC BY 4.0Frontiers in Neurology

Editorial: Monoclonal antibodies in treating multiple sclerosis (MS), and related diseases

  • Abdorreza Naser Moghadasi1
  • Sreeram Ramagopalan2
  • Simona Bonavita3
  • Mahsa Ghajarzadeh4
4 affiliations
  1. 1Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences
  2. 2Centre for Pharmaceutical Medicine Research, King's College London
  3. 3Dipartimento di Scienze Mediche e Chirurgiche Avanzate, Università della Campania Luigi Vanvitelli
  4. 4Department of Neurology, Johns Hopkins University School of Medicine
Open at sourcePDFDOICite

Related

  1. DELPHI expert consensus-derived factors influencing the early use of monoclonal high-efficacy therapies in treatment-naïve patients with relapsing-remitting multiple sclerosis.
    Bertrand Bourre, Olivier Guerrier, Xavier Ayrignac +7
    Journal of neurologyPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. PO068 | ANTIPHOSPHOLIPID ANTIBODIES IN PATIENTS WITH MULTIPLE SCLEROSIS AND MS-LIKE DISEASES: MS OR APS?
    Mariachiara Gagliardi
    Bleeding, Thrombosis and Vascular BiologyPeer-reviewedCC BY-NCFull textCardiovascular medicineDOAJ
  3. Clear Positive MOG Antibodies in Adults With Multiple Sclerosis Features: Diagnostic Challenges.
    Jeanne Garcia, Natalia Shor, Clemence Boutiere +32
    Neurology(R) neuroimmunology & neuroinflammationPeer-reviewedCC BY-NC-NDFull textNeuroscienceGeneral medicineEurope PMCHAL
  4. Novel monoclonal antibodies for an activated protein C cleavage neoepitope of coagulation factor Va
    Research and practice in thrombosis and haemostasisPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Editorial: BCIs for monitoring and treating mental health conditions
    Bettina Habelt, Bettina Habelt, Bettina Habelt +1
    Frontiers in Human NeurosciencePeer-reviewedCC BYFull textNeuroscienceGeneral medicineDOAJ

Cite

BibTeXRIS
BibTeX
@article{moghadasi2026editorial,
  title = {{Editorial: Monoclonal antibodies in treating multiple sclerosis (MS), and related diseases}},
  author = {Abdorreza Naser Moghadasi and Sreeram Ramagopalan and Simona Bonavita and Mahsa Ghajarzadeh},
  journal = {Frontiers in Neurology},
  year = {2026},
  month = sep,
  doi = {10.3389/fneur.2026.1925664},
  url = {https://www.frontiersin.org/articles/10.3389/fneur.2026.1925664/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Editorial: Monoclonal antibodies in treating multiple sclerosis (MS), and related diseases
AU  - Abdorreza Naser Moghadasi
AU  - Sreeram Ramagopalan
AU  - Simona Bonavita
AU  - Mahsa Ghajarzadeh
PY  - 2026
DA  - 2026/09/30
JO  - Frontiers in Neurology
DO  - 10.3389/fneur.2026.1925664
UR  - https://www.frontiersin.org/articles/10.3389/fneur.2026.1925664/full
SN  - 1664-2295
ER  -